The Serial Under Performers

Ian Cassel Blog Leave a Comment

I’ve been investing in micro caps for a very long time and it seems like some stories never die.  Here is a list of stocks (mostly tech cos) that have more lives then a cat and through the years have luckily been able to raise funds to keep the doors open.  The common thread is “paradigm shifting technologies” that are trying to enter huge markets dominated by slow moving large caps.  Now I’m not totally naive as some of these situations might actually work for investors if they show any traction.

ParkerVision, Inc (PRKR) :  engages in the design, development, and sale of proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products. The company offers its wireless technologies for processing RF waveforms in wireless applications. Its technology applies to transmit and receive functions of a radio transceiver.


Broadcast International (BCST): is a leading provider of video-powered broadcast solutions, including IP, and digital satellite, Internet streaming and other types of wired/wireless network distribution. BI’s patented CodecSys software is a breakthrough, multi-codec video compression technology that cuts video bandwidth requirements over satellite, cable, IP and wireless networks.


USA Technologies (USAT):  is a leader in the networking of wireless non-cash transactions, associated financial/network services and energy management. USA Technologies provides networked credit card and other non-cash systems in the vending, commercial laundry, hospitality and digital imaging industries. The Company has been granted 79 patents and has strategic agreements with Verizon, Visa, Crane, Compass and others.


Nanosphere (NSPH):  is using the power of nanotechnology to create innovative molecular diagnostics for the medical field. The Verigene(R) System is an easy-to-use cartridge-based platform that enables rapid, cost-effective, multiplexed testing in a near-patient setting. Current and forthcoming products include clinical diagnostics in the areas of infectious disease, pharmacogenetics, cardiology, and human genetics.



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.